ILK and neoplasm: Activation of the EGFR/FAK pathway can also regulate other signalling molecules, such as Src, Syk, ILK, etc. The EGFR/FAK pathway has been observed to exhibit abnormal expression or activation in numerous tumours and its dysregulation is closely linked to cancer invasion and metastasis.33, 34